1. Home
  2. PHVS

PHVS

Pharvaris N.V.

Logo Pharvaris N.V.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.

Founded: 2015 Country:
Netherlands
Netherlands
Employees: N/A City: N/A
Market Cap: 1.2B IPO Year: 2021
Target Price: $32.00 AVG Volume (30 days): 110.2K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.80 EPS Growth: N/A
52 Week Low/High: $7.93 - $33.00 Next Earning Date: 04-10-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: